• No results found

Darbepoetin Alfa

Extended dosing of darbepoetin alfa in peritoneal dialysis patients

Extended dosing of darbepoetin alfa in peritoneal dialysis patients

... Extended dosing may be advantageous in the manage- ment of anemia in PD patients as it reduces the fre- quency of ESA administration and may enable alignment of ESA administration with routine clinic vis- its, especially ...

8

Reticulocyte dynamic and hemoglobin variability in hemodialysis patients treated with Darbepoetin alfa and C.E.R.A.: a randomized controlled trial

Reticulocyte dynamic and hemoglobin variability in hemodialysis patients treated with Darbepoetin alfa and C.E.R.A.: a randomized controlled trial

... weekly Darbepoetin alfa or Erythropoietin beta to maintain hemoglobin (Hb) tar- ...or Darbepoetin alfa, independent of previous ESAs ...

10

Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial

Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial

... Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III tria[r] ...

5

Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial

Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial

... : Darbepoetin alfa; ELISA: Enzyme linked immunosorbent assay; EOC: End of correction; EOM: End of maintenance; EPO: Erythropoietin alfa; ESA: Erythropoiesis-stimulating agent; ESRD: End- stage renal ...

9

LC MS techniques for analytical testing of recombinant human erythropoietin and darbepoetin alfa in equine plasma samples for anti doping control

LC MS techniques for analytical testing of recombinant human erythropoietin and darbepoetin alfa in equine plasma samples for anti doping control

... Recombinant human EPO (rhEPO) is used for the treatment of clinical anemia by stimulating the production of red blood cells (RBCs). A second generation rhEPO, darbepoetin alfa (Darbe), is a ...

93

Managing chemotherapy induced anemia with darbepoetin alfa and other erythropoiesis stimulating agents: a nurse's perspective

Managing chemotherapy induced anemia with darbepoetin alfa and other erythropoiesis stimulating agents: a nurse's perspective

... section, darbepoetin alfa (DA; Amgen Inc, Thousand Oaks, CA, USA) has been used as a model to represent all ESAs; however, important find- ings from studies of other ESAs have also been included for ...

8

A Randomized, Masked, Placebo-Controlled Study of Darbepoetin Alfa in Preterm Infants

A Randomized, Masked, Placebo-Controlled Study of Darbepoetin Alfa in Preterm Infants

... Erythropoiesis stimulating agents (ESAs) have been used clinically for more than 20 years to stimulate red blood cell production. Erythropoietin (Epo) suc- cessfully stimulates erythropoiesis and decreases transfusion ...

11

Switch from epoetin to darbepoetin alfa in hemodialysis: dose equivalence and hemoglobin stability

Switch from epoetin to darbepoetin alfa in hemodialysis: dose equivalence and hemoglobin stability

... epoetin alfa to darbepoetin alfa in October 2007 (index date) who had been on hemodialysis for at least 15 months before the index date and remained on hemodialysis for at least 24 months after ...

7

Effects of darbepoetin alfa and epoetin beta pegol on iron kinetics in hemodialysis patients

Effects of darbepoetin alfa and epoetin beta pegol on iron kinetics in hemodialysis patients

... tin alfa (DPO), and epoetin beta pegol (continuous erythropoietin receptor activator; CERA) are widely used in current clinical practice for the treatment of anemia in hemodialysis ...

7

Hemoglobin Level Stability after a Switch from Darbepoetin Alfa to Epoetin Beta Pegol for the Treatment of Renal Anemia in Hemodialysis Patients

Hemoglobin Level Stability after a Switch from Darbepoetin Alfa to Epoetin Beta Pegol for the Treatment of Renal Anemia in Hemodialysis Patients

... Dalbepoetin alfa (DA) has a much longer half-life and longer erythropoietic effect than epoetin alfa [6] [7]. The initially recommended conversion rate was 200 IU of epoetin alfa per 1 μg of DA [8]. ...

9

Effects of Darbepoetin α on Oxidative  Stress Marker in Patients with Chronic  Renal Failure

Effects of Darbepoetin α on Oxidative Stress Marker in Patients with Chronic Renal Failure

... of darbepoetin alfa on Plasma Mediators of Oxidative and Ni- trosative Stress in Anemic Patients with Chronic Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardi- ...

5

Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C:a retrospective study using the Japanese Interferon Database

Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C:a retrospective study using the Japanese Interferon Database

... Our study also has several limitations. First, there were residual confounders, which could persist due to unmeasured or imprecisely measured potential confounding factors. To adjust for potential confounders, we used ...

8

Pathophysiology of hypophosphatasia and the potential role of asfotase alfa

Pathophysiology of hypophosphatasia and the potential role of asfotase alfa

... (asfotase alfa) was reported in 2008, and subsequently success in patients with severe form of the disease was reported in ...asfotase alfa was approved in Japan in July, followed by in the EU and Canada in ...

10

(choriogonadotropin alfa injection) FOR SUBCUTANEOUS USE DESCRIPTION

(choriogonadotropin alfa injection) FOR SUBCUTANEOUS USE DESCRIPTION

... Choriogonadotropin alfa is secreted by the CHO cells directly into the cell culture medium that is then purified using a series of chromatographic ...choriogonadotropin alfa is determined using the seminal ...

14

Key coding for Fiat / Alfa / Lancia / Iveco

Key coding for Fiat / Alfa / Lancia / Iveco

... Transponder Philips Crypto, key contains pre-programmed data for a specific vehicle (the dealer key). Key coding is not supported at this time[r] ...

7

Practical aspects of treatment with drotrecogin alfa (activated)

Practical aspects of treatment with drotrecogin alfa (activated)

... A condition of the initial approval of DrotAA by the FDA in 2001 was that additional data were to be provided and further trials conducted. Specifically, data from the long-term follow up of survivors from the PROWESS ...

8

A prospective Study on Adverse Drug Reactions from Pegylated Interferon Alfa-2a and Alfa-2b in Combination with Ribavirin in Hepatitis B and C

A prospective Study on Adverse Drug Reactions from Pegylated Interferon Alfa-2a and Alfa-2b in Combination with Ribavirin in Hepatitis B and C

... peginterferon alfa- 2a and alfa- 2b safety, with or without ribavirin, the treatment of HCV are based on large phase III trials including more than 1100 patients ...peginterferon alfa 2a and ...

6

Credit Opinion: Banco Alfa de Investimento S.A.

Credit Opinion: Banco Alfa de Investimento S.A.

... Traditionally, Alfa maintains a vigilant management of liquidity gaps, as executives pursue optimized diversification in order to support lending expansion and ...as Alfa has been using this local debt ...

10

A scalable and asynchronous detector simulation system based on ALFA

A scalable and asynchronous detector simulation system based on ALFA

... We will report here on the implementation of a scalable and asynchronous de- tector simulation system which is based on ALFA. The system offers paral- lelization at the primary-track level, going beyond the usual ...

8

Show all 194 documents...

Related subjects